自身免疫性肺泡蛋白沉积症大剂量粒细胞巨噬细胞集落刺激因子治疗期间的肺动脉高压 - Suppr | 超能文献

Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis.

作者信息

Ataya Ali, Mitchel Stephen, Carey Brenna, Sippel Jeffrey, McCarthy Cormac, Trapnell Bruce C

机构信息

Division of Pulmonary and Critical Care Medicine University of Florida Gainesville Florida USA.

Translational Pulmonary Science Center Cincinnati Children's Hospital Cincinnati Ohio USA.

出版信息

Pulm Circ. 2024 Nov 21;14(4):e70020. doi: 10.1002/pul2.70020. eCollection 2024 Oct.

DOI:10.1002/pul2.70020

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11582013/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ab/11582013/85e31e868f49/PUL2-14-e70020-g001.jpg

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis.自身免疫性肺泡蛋白沉积症大剂量粒细胞巨噬细胞集落刺激因子治疗期间的肺动脉高压

Pulm Circ. 2024 Nov 21;14(4):e70020. doi: 10.1002/pul2.70020. eCollection 2024 Oct.

2

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.吸入 GM-CSF 治疗肺泡蛋白沉积症。

N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216.

3

Assay system development to measure the concentration of sargramostim with high specificity in patients with autoimmune pulmonary alveolar proteinosis after single-dose inhalation.开发检测体系，以高特异性测定单次吸入治疗后自身免疫性肺泡蛋白沉积症患者体内的沙莫司汀浓度。

J Immunol Methods. 2018 Sep;460:1-9. doi: 10.1016/j.jim.2018.05.012. Epub 2018 Jul 9.

4

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.粒细胞-巨噬细胞集落刺激因子自身抗体在感染和自身免疫性肺泡蛋白沉积症中的作用：简要综述

Front Immunol. 2021 Nov 22;12:752856. doi: 10.3389/fimmu.2021.752856. eCollection 2021.

5

Successful granulocyte-macrophage colony-stimulating factor inhalation therapy for recurrent autoimmune pulmonary alveolar proteinosis after lung transplantation: A case report.肺移植术后复发性自身免疫性肺泡蛋白沉积症的成功粒细胞-巨噬细胞集落刺激因子吸入治疗：一例报告

Respir Investig. 2025 Jan;63(1):180-182. doi: 10.1016/j.resinv.2024.12.001. Epub 2025 Jan 4.

6

Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.吸入粒细胞-巨噬细胞集落刺激因子治疗轻中度自身免疫性肺泡蛋白沉积症 - 一项 24 个月随访的 6 个月 2 期随机研究。

Orphanet J Rare Dis. 2020 Jul 2;15(1):174. doi: 10.1186/s13023-020-01450-4.

7

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.抗粒细胞巨噬细胞集落刺激因子自身抗体对肺泡蛋白沉积症具有诊断意义。

Am J Respir Cell Mol Biol. 2002 Oct;27(4):481-6. doi: 10.1165/rcmb.2002-0023OC.

8

Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.治疗自身免疫性肺泡蛋白沉积症的更好方法：吸入或皮下粒细胞-巨噬细胞集落刺激因子：荟萃分析。

Respir Res. 2018 Aug 31;19(1):163. doi: 10.1186/s12931-018-0862-4.

9

Response to inhaled granulocyte-macrophage colony-stimulating factor in patient with mild-to-moderate autoimmune pulmonary alveolar proteinosis-24 months of follow-up.吸入粒细胞-巨噬细胞集落刺激因子治疗轻中度自身免疫性肺泡蛋白沉积症患者的反应 - 24 个月随访结果。

Clin Respir J. 2023 Oct;17(10):1077-1081. doi: 10.1111/crj.13650. Epub 2023 Jun 10.

10

Nebulised granulocyte-macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis.雾化粒细胞-巨噬细胞集落刺激因子（GM-CSF）治疗自身免疫性肺泡蛋白沉积症：系统评价和荟萃分析。

Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0080-2023. Print 2023 Dec 31.

引用本文的文献

1

Granulocyte-Macrophage Colony-Stimulating Factor Inhibition Ameliorates Innate Immune Cell Activation, Inflammation, and Salt-Sensitive Hypertension.粒细胞-巨噬细胞集落刺激因子抑制可改善先天性免疫细胞活化、炎症和盐敏感性高血压。

Cells. 2025 Jul 24;14(15):1144. doi: 10.3390/cells14151144.